These results were supported by another large study reporting elevated levels of circulating chemerin in NSCLC patients, and higher levels of chemerin being associated with advanced TNM stage, lymph node metastasis and distant metastasis. Here, RARRES2 is linked to metastatic malignant neoplasm in the lymph nodes.